# 🏥 PHARMALINK ENTERPRISE
## Enterprise Technical Documentation & Handover Package

**Package Reference**: `PHARMALINK-CORP-DOCS-2026`  
**Document Classification**: Enterprise Confidential  
**Document Type**: Technical Handover & System Documentation  
**Version**: 1.0  
**Status**: Engineering Review / Handover  
**Target Audience**: Executive Leadership, Product Management, Solution Architects, Engineering, QA, DevOps, Operations, Security & Compliance Teams

---

## 1. Document Purpose

This documentation package provides a consolidated technical, architectural, security, operational, and developer reference for the PharmaLink Enterprise platform.

The package is intended to support:
- Executive and technical review
- Architecture assessment
- Product requirement validation
- Engineering handover
- Developer onboarding
- Security assessment
- QA and testing activities
- Deployment and operational support
- Future maintenance and enhancement
- Production readiness assessment

All documentation is maintained under the `reports/` directory and is organized into five primary volumes.

---

## 2. Executive Documentation Index

| Volume | Document Name | File Path | Primary Scope |
| :--- | :--- | :--- | :--- |
| **Volume 1** | Executive Project Overview & PRD Compliance | [`reports/01_EXECUTIVE_PROJECT_OVERVIEW_AND_PRD.md`](file:///d:/PharmaLink%20Enterprise%20application/reports/01_EXECUTIVE_PROJECT_OVERVIEW_AND_PRD.md) | Business overview, product requirements, personas, scope and compliance |
| **Volume 2** | System Architecture & Infrastructure | [`reports/02_SYSTEM_ARCHITECTURE_AND_INFRASTRUCTURE.md`](file:///d:/PharmaLink%20Enterprise%20application/reports/02_SYSTEM_ARCHITECTURE_AND_INFRASTRUCTURE.md) | Architecture, infrastructure, data flow, database and system topology |
| **Volume 3** | Complete REST API Specification | [`reports/03_COMPLETE_REST_API_SPECIFICATION.md`](file:///d:/PharmaLink%20Enterprise%20application/reports/03_COMPLETE_REST_API_SPECIFICATION.md) | REST APIs, authentication, products, orders, payments, KYC, users and reporting |
| **Volume 4** | Enterprise Security & Compliance Audit | [`reports/04_ENTERPRISE_SECURITY_AND_COMPLIANCE_AUDIT.md`](file:///d:/PharmaLink%20Enterprise%20application/reports/04_ENTERPRISE_SECURITY_AND_COMPLIANCE_AUDIT.md) | Authentication, authorization, security controls, audit logging and security testing |
| **Volume 5** | Step-by-Step Implementation & Developer Guide | [`reports/05_STEP_BY_STEP_IMPLEMENTATION_AND_DEVELOPER_GUIDE.md`](file:///d:/PharmaLink%20Enterprise%20application/reports/05_STEP_BY_STEP_IMPLEMENTATION_AND_DEVELOPER_GUIDE.md) | Development setup, implementation, testing, deployment and operational procedures |

---

## 3. Platform Overview

PharmaLink Enterprise is a full-stack pharmaceutical commerce and supply-chain platform supporting both B2B wholesale distribution and B2C retail commerce workflows.

The platform is designed to support controlled pharmaceutical commerce through:
- Role-based access control (RBAC)
- Distributor verification and KYC
- GSTIN and Drug License validation workflows
- Dynamic pricing (Retail MRP vs. Distributor Wholesale vs. Bulk MOQ)
- Wholesale and retail purchasing models
- Product and inventory management
- Order lifecycle management (Pending ➔ Confirmed ➔ Packed ➔ Shipped ➔ Delivered)
- Payment processing (Razorpay & COD)
- Audit logging and sanitization
- Commercial reporting and analytics
- Security and access controls
- Multi-persona business workflows

---

## 4. Documentation Governance

The documentation package follows a structured enterprise documentation model. Each volume has a defined scope and should be treated as an independent technical reference while maintaining cross-references to related documentation.

### Documentation Ownership Matrix

| Responsibility | Owner |
| :--- | :--- |
| **Product Requirements** | Product Management |
| **Solution Architecture** | Architecture / Engineering |
| **API Specification** | Backend Engineering |
| **Security Documentation** | Security / Engineering |
| **Developer Documentation** | Engineering |
| **Deployment Documentation** | DevOps / Engineering |
| **QA Evidence** | Quality Engineering |
| **Final Approval** | Engineering / Technical Leadership |

---

## 5. Volume Summaries

### Volume 1 — Executive Project Overview & PRD Compliance
- **Document**: [`01_EXECUTIVE_PROJECT_OVERVIEW_AND_PRD.md`](file:///d:/PharmaLink%20Enterprise%20application/reports/01_EXECUTIVE_PROJECT_OVERVIEW_AND_PRD.md)
- **Scope**: Provides executive-level understanding of PharmaLink Enterprise, including business objectives, product scope, user personas, requirements, and implementation status.
- **Primary Audience**: Executive Leadership, Product Managers, Business Analysts, Solution Architects, Engineering Leads.

### Volume 2 — System Architecture & Infrastructure
- **Document**: [`02_SYSTEM_ARCHITECTURE_AND_INFRASTRUCTURE.md`](file:///d:/PharmaLink%20Enterprise%20application/reports/02_SYSTEM_ARCHITECTURE_AND_INFRASTRUCTURE.md)
- **Scope**: Defines the technical architecture, data flow, component topology, database ER schemas, and backend/frontend module breakdown.
- **Primary Audience**: Solution Architects, Senior Developers, Infrastructure & Operations Teams.

### Volume 3 — Complete REST API Specification
- **Document**: [`03_COMPLETE_REST_API_SPECIFICATION.md`](file:///d:/PharmaLink%20Enterprise%20application/reports/03_COMPLETE_REST_API_SPECIFICATION.md)
- **Scope**: Provides the complete REST API reference for all endpoints across Auth, Products, Inventory, Orders, Invoices, KYC, Payments, Reports, Audit, and Users.
- **Primary Audience**: Backend & Frontend Engineers, Integration Partners, QA Teams.

### Volume 4 — Enterprise Security & Compliance Audit
- **Document**: [`04_ENTERPRISE_SECURITY_AND_COMPLIANCE_AUDIT.md`](file:///d:/PharmaLink%20Enterprise%20application/reports/04_ENTERPRISE_SECURITY_AND_COMPLIANCE_AUDIT.md)
- **Scope**: Details security architecture, JWT token claims, RBAC dependencies, IDOR/BOLA controls, rate limiting, sensitive data redaction, and 26/26 passed security test suite.
- **Primary Audience**: Information Security Teams, Compliance Auditors, Lead Engineers.

### Volume 5 — Step-by-Step Implementation & Developer Guide
- **Document**: [`05_STEP_BY_STEP_IMPLEMENTATION_AND_DEVELOPER_GUIDE.md`](file:///d:/PharmaLink%20Enterprise%20application/reports/05_STEP_BY_STEP_IMPLEMENTATION_AND_DEVELOPER_GUIDE.md)
- **Scope**: Primary engineering onboarding guide covering setup, feature mechanics, stock locking, atomic transactions, test execution commands, and developer golden rules.
- **Primary Audience**: Software Engineers, DevOps, System Administrators.

---

## 6. Security Test Status & Verification

### Automated Security Test Execution
```bash
# Execute 26 Automated Security Tests
python backend/tests/test_security_auth.py
```

### Current Test Result Summary
- **Security Tests Executed**: 26
- **Security Tests Passed**: 26
- **Security Tests Failed**: 0
- **Pass Rate**: 100%

---

## 7. Quality & Validation Matrix

| Validation Area | Current Status | Notes |
| :--- | :--- | :--- |
| **Functional Requirements** | **Assessed** | 100% Phase 1 PRD Features Verified |
| **PRD Traceability** | **Assessed** | Verified across Web, Customer, B2B Distributor, and Admin Portals |
| **Authentication** | **Validated** | Short-lived HS256 JWT (15-min TTL) & Bcrypt password hashing |
| **Authorization / RBAC** | **Validated** | Authoritative database role verification via `require_roles()` |
| **IDOR / BOLA Controls** | **Validated** | Resource ownership checks on `/orders/{id}` and `/invoice` |
| **Rate Limiting** | **Validated** | In-memory sliding window (5 failed attempts / 60s -> HTTP 429) |
| **Audit Sanitization** | **Validated** | Automatic Regex redaction of passwords, tokens, PANs, and secrets |
| **Security Test Suite** | **26/26 Passed** | Clean exit code 0 |
| **Payment Verification** | **Tested** | HMAC-SHA256 signature verification for Razorpay |
| **Backend Integration** | **Tested** | Clean integration test suite execution |

---

## 8. Document Control & Revision History

| Version | Date | Author | Description | Reviewer | Status |
| :--- | :--- | :--- | :--- | :--- | :--- |
| **1.0** | 19-Aug-2026 | Engineering | Initial enterprise documentation handover package | Technical Leadership | Approved / Handover |

---

**Documentation Status**: Enterprise Handover Package  
**Package Reference**: `PHARMALINK-CORP-DOCS-2026`  
**Classification**: Enterprise Confidential  
**Version**: 1.0
